InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (16 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
16
T+90 hit rate
40%
T+90 mean return
-6.6%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Harford Simon N.R., Chief Financial Officer. Director active across 2 companies, notably Albireo Pharma, INC.. In total, 26 disclosures have been published. Breakdown: 0 buy · 16 sells. Total volume traded: €125k. History available since 13 July 2021. The latest transaction was disclosed on 26 December 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Declarations26 total
71,303 shares@ US$14.2580.9% of flowCommon StockSEC:0001193125-25-337337:0
7,482 shares@ US$9.316.3% of flowCommon StockSEC:0000950170-25-002421:0
12,529 shares@ US$12.0912.7% of flowCommon StockSEC:0000950170-24-100253:0
57,392 shares0Common StockSEC:0000950170-24-002094:0
106,973 shares0Common StockSEC:0001209191-23-047104:0
13,739 sharesCommon StockSEC:0001209191-23-014786:0
55,000 shares0Common StockSEC:0001209191-23-005333:0
55,000 shares0Common StockSEC:0001209191-23-004948:0
102 shares@ US$43.803.3% of flowCommon StockSEC:0001209191-23-004453:0
1,776 shares@ US$43.8057.5% of flowCommon StockSEC:0001209191-23-004219:0
104 shares@ US$19.57641.6% of flowCommon StockSEC:0001209191-22-054487:0
80 shares@ US$23.78581.6% of flowCommon StockSEC:0001209191-22-053556:0
106 shares@ US$24.67132.0% of flowCommon StockSEC:0001209191-22-043106:0
95 shares@ US$24.02761.8% of flowCommon StockSEC:0001209191-22-042038:0
103 shares@ US$32.92477.8% of flowCommon StockSEC:0001209191-22-025525:0
96 shares@ US$35.74397.8% of flowCommon StockSEC:0001209191-22-023974:0
416 shares@ US$24.88227.3% of flowCommon StockSEC:0001209191-22-004807
416 shares@ US$24.882222.6% of flowCommon StockSEC:0001209191-22-004807:0
21,600 shares0Common StockSEC:0001209191-22-004063
21,600 shares0Common StockSEC:0001209191-22-004063:0
111 shares@ US$25.94642.0% of flowCommon StockSEC:0001209191-22-002923
111 shares@ US$25.94646.3% of flowCommon StockSEC:0001209191-22-002923:0
93 shares@ US$30.23396.0% of flowCommon StockSEC:0001209191-21-060216:0
93 shares@ US$30.23391.9% of flowCommon StockSEC:0001209191-21-060216
98 shares@ US$35.027.2% of flowCommon StockSEC:0001209191-21-046787:0
25 of 26 declarations
About Harford Simon N.R.
Simon N.R. Harford is the Chief Financial Officer and Treasurer at ALBIREO PHARMA, INC. He oversees the company's financial operations, including budget management and forecasting. His role is crucial in ensuring the financial health and growth of Albireo Pharma.
